ML239 is a potent and selective inhibitor of breast cancer stem cells, with an IC50 of 1.16 μM.
体外研究
ML239 (Compound 7j) is a potent and selective inhibitor of breast cancer stem cells, with an IC50 of 1.16 μM, with ∼24-fold selectivity against the control cell line. ML239 inhibits breast cancer stem-like cells, most likely through activation of fatty acid desaturase 2 (FADS2). ML239 is cytotoxic to NCIH661 cells, and FADS2 knockdown reduces ML239 cytotoxicity, and furthermore, FADS2 inhibitor SC-26196 also reduces ML239 cytotoxicity in cancer cell lines (CCLs).
分子式
C13H10Cl3N3O2
分子量
346.60
CAS号
1378872-36-6
运输条件
Room temperature in continental US; may vary elsewhere.